We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Oxford Industries
OXM
$538M
| $344K | ﹤0.01% |
3,687
+1,307
| +55% | +$131K |
|
1327
Definitive Healthcare
DH
$69.4M
| $338K | ﹤0.01% |
30,746
-108,041
| -78% | -$1.39M |
|
1328
McKesson
MCK
$102B
| $334K | ﹤0.01% |
+890
| New | +$332K |
|
1329
US Physical Therapy
USPH
$1.22B
| $332K | ﹤0.01% |
4,097
-1,773
| -30% | -$149K |
|
1330
First Majestic Silver
AG
$9.44B
| $330K | ﹤0.01% |
39,553
-58,900
| -60% | -$514K |
|
1331
Group 1 Automotive
GPI
$3.17B
| $329K | ﹤0.01% |
1,826
-1,419
| -44% | -$250K |
|
1332
Zymeworks
ZYME
$1.77B
| $329K | ﹤0.01% |
41,821
-248,789
| -86% | -$1.75M |
|
1333
AGCO
AGCO
$7.11B
| $326K | ﹤0.01% |
2,347
-20,604
| -90% | -$2.54M |
|
1334
Illumina
ILMN
$29.1B
| $325K | ﹤0.01% |
1,652
-73,895
| -98% | -$15.3M |
|
|
MDC
1335
DELISTED
M.D.C. Holdings, Inc.
MDC
| $323K | ﹤0.01% |
10,231
-59,193
| -85% | -$1.83M |
|
|
ATCO
1336
DELISTED
Atlas Corp.
ATCO
| $319K | ﹤0.01% |
+20,785
| New | +$314K |
|
1337
Nucor
NUE
$61.9B
| $318K | ﹤0.01% |
2,412
-7,375
| -75% | -$1M |
|
1338
SAP
SAP
$236B
| $316K | ﹤0.01% |
3,059
-8,392
| -73% | -$840K |
|
1339
CNO Financial Group
CNO
$5.02B
| $314K | ﹤0.01% |
13,763
-175,715
| -93% | -$3.79M |
|
1340
First Advantage
FA
$3.61B
| $304K | ﹤0.01% |
+23,406
| New | +$306K |
|
1341
International Bancshares
IBOC
$4.52B
| $303K | ﹤0.01% |
+6,632
| New | +$319K |
|
1342
Masco
MAS
$14.7B
| $295K | ﹤0.01% |
+6,325
| New | +$305K |
|
1343
COPT Defense Properties
CDP
$4.19B
| $295K | ﹤0.01% |
+11,365
| New | +$292K |
|
|
SPLK
1344
DELISTED
Splunk Inc
SPLK
| $290K | ﹤0.01% |
+3,366
| New | +$272K |
|
1345
Kura Sushi USA
KRUS
$637M
| $287K | ﹤0.01% |
6,019
-14,503
| -71% | -$964K |
|
1346
Exponent
EXPO
$3.22B
| $273K | ﹤0.01% |
+2,752
| New | +$267K |
|
1347
Inspire Medical Systems
INSP
$1.68B
| $272K | ﹤0.01% |
+1,079
| New | +$230K |
|
1348
Idacorp
IDA
$8.21B
| $271K | ﹤0.01% |
2,517
-4,873
| -66% | -$505K |
|
1349
Paylocity
PCTY
$7.73B
| $270K | ﹤0.01% |
+1,389
| New | +$298K |
|
1350
Relay Therapeutics
RLAY
$4.4B
| $266K | ﹤0.01% |
17,835
-294,749
| -94% | -$5.64M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.